Now showing items 31-40 of 90
Pharmacy Benefit Management, Cost-Effectiveness Analysis and Drug Formulary Decisions
(Social Science & Medicine, 1997-08)
The Evolution of the Pharmaceutical Industry Over the Past 50 Years: A Personal Reflection
(International Journal of the Economics of Business, 2011-07)
Innovation in the pharmaceutical industry: New estimates of R&D costs.
(J Health Econ, 2016-05)
The research and development costs of 106 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug and biologics development. ...
Increasing R&D Incentives for Neglected Diseases: Lessons from the Orphan Drug Act
(International Public Goods And Transfer Of Technology Under A Globalized Intellectual Property Regime, 2005)
Patents and New Product Development in the Pharmaceutical and Biotechnology Industry
(The Georgetown Public Policy Review, 2003-03)
A New Look at the Returns and Risks to Pharmaceutical R & D
(Management Science, 1990-07)
Recent Trends in Brand-Name and Generic Drug Competition
(Journal of Medical Economics, 2013)
The price of innovation: new estimates of drug development costs.
(J Health Econ, 2003-03)
The research and development costs of 68 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug development. The costs of ...
The Pharmaceutical Industry
FISHER and TEMIN (1973) have argued recently that many empirical studies1 relating to the Schumpeterian hypothesis are inappropriate for testing that hypothesis. They observe that Schumpeter can be interpreted as hypothesizing ...